Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01947140 · ADVERSE EVENTS

Adverse events

Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies · Source last updated 2026-09-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
up to 3 years
Other-event reporting threshold
0%
Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Pralatrexate 10 mg/m2, Romidepsin 12mg/m2

Cohort 1, Dose Level -1 Subjects will be administered through IV: Pralatrexate10 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 12mg/m2 on days 1 and 8 of each 21 daycycle

0 / 33 / 30 / 3
Phase 1 Schedule A: Pralatrexate 15 mg/m2, Romidepsin 12 mg/m2

Cohort 2A, Dose Level 1 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 12 mg/m2 on days 1 and 8 of each 21 day cycle.

1 / 33 / 31 / 3
Phase 1 Schedule B: Pralatrexate 15 mg/m2, Romidepsin 12 mg/m2

Cohort 2B, Dose Level 1 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.

0 / 33 / 30 / 3
Phase 1 Schedule A: Pralatrexate 15 mg/m2, Romidepsin 14 mg/m2

Cohort 3A, Dose Level 2 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 14 mg/m2 on days 1 and 8 of each 21 day cycle.

1 / 33 / 30 / 3
Phase 1 Schedule B: Pralatrexate 15 mg/m2, Romidepsin 14 mg/m2

Cohort 3B, Dose Level 2 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 14 mg/m2 on days 1 and 15 of each 28 day cycle.

1 / 33 / 32 / 3
Phase 1 Schedule A: Pralatrexate 20 mg/m2, Romidepsin 12 mg/m2

Cohort 4A, Dose Level 3 Subjects will be administered through IV: Pralatrexate 20 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 12 mg/m2 on days 1 and 8 of each 21 day cycle.

2 / 55 / 50 / 5
Phase 1 Schedule B: Pralatrexate 20 mg/m2, Romidepsin 12 mg/m2

Cohort 4B, Dose Level 3 Subjects will be administered through IV: Pralatrexate 20 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.

1 / 33 / 30 / 3
Phase 1 Schedule B: Pralatrexate 25 mg/m2, Romidepsin 12 mg/m2

Cohort 5B, Dose Level 4 Subjects will be administered through IV: Pralatrexate 25 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.

2 / 66 / 60 / 6
Phase 2: Pralatrexate 25 mg/m2, Romidepsin 12 mg/m2

Subjects will be administered through IV: Pralatrexate 25 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.

4 / 1813 / 181 / 18

Group identifiers: EG000: Pralatrexate 10 mg/m2, Romidepsin 12mg/m2 · EG001: Phase 1 Schedule A: Pralatrexate 15 mg/m2, Romidepsin 12 mg/m2 · EG002: Phase 1 Schedule B: Pralatrexate 15 mg/m2, Romidepsin 12 mg/m2 · EG003: Phase 1 Schedule A: Pralatrexate 15 mg/m2, Romidepsin 14 mg/m2 · EG004: Phase 1 Schedule B: Pralatrexate 15 mg/m2, Romidepsin 14 mg/m2 · EG005: Phase 1 Schedule A: Pralatrexate 20 mg/m2, Romidepsin 12 mg/m2 · EG006: Phase 1 Schedule B: Pralatrexate 20 mg/m2, Romidepsin 12 mg/m2 · EG007: Phase 1 Schedule B: Pralatrexate 25 mg/m2, Romidepsin 12 mg/m2 · EG008: Phase 2: Pralatrexate 25 mg/m2, Romidepsin 12 mg/m2

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Abdominal pain
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      1
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Anemia
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Appendicitis
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Colonic hemorrhage
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Constipation
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Immune system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Erythema multiforme
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Immune system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      1
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Febrile neutropenia
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Infections and infestations
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      2
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Lung infection
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Immune system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Lymph gland infection
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      1
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Mucositis oral
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Neoplasms benign, malignant and unspecified (incl cysts and polyps)
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Neoplasms benign, malignant and unspecified
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Non-cardiac chest pain

Other reported adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      2
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      1
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      2
      num At Risk
      18
    term
    Abdominal pain
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      1
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Allergic rhinitis
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      2
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      2
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      3
      num At Risk
      18
    term
    Anemia
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      3
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      2
      num At Risk
      18
    term
    Anorexia
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Anxiety
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Atrial fibrillation
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      1
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Back pain
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Bloating
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Blood bilirubin increased
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Eye disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Blurred vision
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Infections and infestations
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      1
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    C. difficle infection
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Chills
Complete source fields
event Groups
  1. deaths Num Affected
    0
    deaths Num At Risk
    3
    description
    Cohort 1, Dose Level -1 Subjects will be administered through IV: Pralatrexate10 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 12mg/m2 on days 1 and 8 of each 21 daycycle
    id
    EG000
    other Num Affected
    3
    other Num At Risk
    3
    serious Num Affected
    0
    serious Num At Risk
    3
    title
    Pralatrexate 10 mg/m2, Romidepsin 12mg/m2
  2. deaths Num Affected
    1
    deaths Num At Risk
    3
    description
    Cohort 2A, Dose Level 1 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 12 mg/m2 on days 1 and 8 of each 21 day cycle.
    id
    EG001
    other Num Affected
    3
    other Num At Risk
    3
    serious Num Affected
    1
    serious Num At Risk
    3
    title
    Phase 1 Schedule A: Pralatrexate 15 mg/m2, Romidepsin 12 mg/m2
  3. deaths Num Affected
    0
    deaths Num At Risk
    3
    description
    Cohort 2B, Dose Level 1 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.
    id
    EG002
    other Num Affected
    3
    other Num At Risk
    3
    serious Num Affected
    0
    serious Num At Risk
    3
    title
    Phase 1 Schedule B: Pralatrexate 15 mg/m2, Romidepsin 12 mg/m2
  4. deaths Num Affected
    0
    deaths Num At Risk
    3
    description
    Cohort 3A, Dose Level 2 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 14 mg/m2 on days 1 and 8 of each 21 day cycle.
    id
    EG003
    other Num Affected
    3
    other Num At Risk
    3
    serious Num Affected
    1
    serious Num At Risk
    3
    title
    Phase 1 Schedule A: Pralatrexate 15 mg/m2, Romidepsin 14 mg/m2
  5. deaths Num Affected
    2
    deaths Num At Risk
    3
    description
    Cohort 3B, Dose Level 2 Subjects will be administered through IV: Pralatrexate 15 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 14 mg/m2 on days 1 and 15 of each 28 day cycle.
    id
    EG004
    other Num Affected
    3
    other Num At Risk
    3
    serious Num Affected
    1
    serious Num At Risk
    3
    title
    Phase 1 Schedule B: Pralatrexate 15 mg/m2, Romidepsin 14 mg/m2
  6. deaths Num Affected
    0
    deaths Num At Risk
    5
    description
    Cohort 4A, Dose Level 3 Subjects will be administered through IV: Pralatrexate 20 mg/m2 on days 1 and 8 of each 21 day cycle. Romidepsin 12 mg/m2 on days 1 and 8 of each 21 day cycle.
    id
    EG005
    other Num Affected
    5
    other Num At Risk
    5
    serious Num Affected
    2
    serious Num At Risk
    5
    title
    Phase 1 Schedule A: Pralatrexate 20 mg/m2, Romidepsin 12 mg/m2
  7. deaths Num Affected
    0
    deaths Num At Risk
    3
    description
    Cohort 4B, Dose Level 3 Subjects will be administered through IV: Pralatrexate 20 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.
    id
    EG006
    other Num Affected
    3
    other Num At Risk
    3
    serious Num Affected
    1
    serious Num At Risk
    3
    title
    Phase 1 Schedule B: Pralatrexate 20 mg/m2, Romidepsin 12 mg/m2
  8. deaths Num Affected
    0
    deaths Num At Risk
    6
    description
    Cohort 5B, Dose Level 4 Subjects will be administered through IV: Pralatrexate 25 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.
    id
    EG007
    other Num Affected
    6
    other Num At Risk
    6
    serious Num Affected
    2
    serious Num At Risk
    6
    title
    Phase 1 Schedule B: Pralatrexate 25 mg/m2, Romidepsin 12 mg/m2
  9. deaths Num Affected
    1
    deaths Num At Risk
    18
    description
    Subjects will be administered through IV: Pralatrexate 25 mg/m2 on days 1 and 15 of each 28 day cycle. Romidepsin 12 mg/m2 on days 1 and 15 of each 28 day cycle.
    id
    EG008
    other Num Affected
    13
    other Num At Risk
    18
    serious Num Affected
    4
    serious Num At Risk
    18
    title
    Phase 2: Pralatrexate 25 mg/m2, Romidepsin 12 mg/m2
frequency Threshold
0
other Events
  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      2
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      1
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      2
      num At Risk
      18
    term
    Abdominal pain
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      1
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Allergic rhinitis
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      2
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      2
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      3
      num At Risk
      18
    term
    Anemia
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      3
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      2
      num At Risk
      18
    term
    Anorexia
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Anxiety
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Cardiac disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Atrial fibrillation
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      1
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Back pain
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      1
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Bloating
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Blood bilirubin increased
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Eye disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Blurred vision
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Infections and infestations
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      1
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    C. difficle infection
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Chills
serious Events
  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Abdominal pain
  2. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Blood and lymphatic system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      1
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Anemia
  3. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Appendicitis
  4. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Colonic hemorrhage
  5. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Gastrointestinal disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      1
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Constipation
  6. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Immune system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Erythema multiforme
  7. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Immune system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      1
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      1
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Febrile neutropenia
  8. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Infections and infestations
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      2
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Lung infection
  9. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Immune system disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      1
      num At Risk
      18
    term
    Lymph gland infection
  10. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      1
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Mucositis oral
  11. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    Neoplasms benign, malignant and unspecified (incl cysts and polyps)
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      0
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      1
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Neoplasms benign, malignant and unspecified
  12. assessment Type
    SYSTEMATIC_ASSESSMENT
    organ System
    General disorders
    stats
    1. group Id
      EG000
      num Affected
      0
      num At Risk
      3
    2. group Id
      EG001
      num Affected
      1
      num At Risk
      3
    3. group Id
      EG002
      num Affected
      0
      num At Risk
      3
    4. group Id
      EG003
      num Affected
      0
      num At Risk
      3
    5. group Id
      EG004
      num Affected
      0
      num At Risk
      3
    6. group Id
      EG005
      num Affected
      0
      num At Risk
      5
    7. group Id
      EG006
      num Affected
      0
      num At Risk
      3
    8. group Id
      EG007
      num Affected
      0
      num At Risk
      6
    9. group Id
      EG008
      num Affected
      0
      num At Risk
      18
    term
    Non-cardiac chest pain
time Frame
up to 3 years

Download exact source JSON → · Snapshot ctgov-results-d643ffaf417bcef6d45eb5e0

Preserved source evidence · Not medical advice